Global Hepatitis C Virus (HCV) Market Insights, Forecast to 2028

Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Hepatitis C Virus (HCV) estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Hepatitis C Virus (HCV) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Hepatitis C Virus (HCV) market. Further, it explains the major drivers and regional dynamics of the global Hepatitis C Virus (HCV) market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Gilead

Merck

AbbVie

J&J

Bristol-Myers Squibb

Kawin

Abbott

Siemens Healthineers

Roche Diagnostics

altona Diagnostics

GeneProof

Sansure Biotech

Daan Gene

BGI Group

Abiores

ACON Biotech

Nectar Lifesciences

Everlywell

bioLytical

Liferiver

3B BlackBio Biotech India Limited

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Hepatitis C Drugs

Hepatitis C Test Kit

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Hepatitis C Virus (HCV) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Hepatitis C Virus (HCV) market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Hepatitis C Virus (HCV), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hepatitis C Virus (HCV), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hepatitis C Virus (HCV) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Hepatitis C Virus (HCV) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Hepatitis C Virus (HCV) revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Gilead, Merck, AbbVie, J&J, Bristol-Myers Squibb, Kawin, Abbott, Siemens Healthineers and Roche Diagnostics, etc.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Hepatitis C Virus (HCV) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatitis C Virus (HCV) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.

Chapter 9: Latin America by type, by application and by country, revenue for each segment.

Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis C Virus (HCV) revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Hepatitis C Drugs

1.2.3 Hepatitis C Test Kit

1.3 Market by Application

1.3.1 Global Hepatitis C Virus (HCV) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.4 Study Objectives

1.5 Years Considered

2.1 Global Hepatitis C Virus (HCV) Market Perspective (2017-2028)

2.2 Hepatitis C Virus (HCV) Growth Trends by Region

2.2.1 Hepatitis C Virus (HCV) Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Hepatitis C Virus (HCV) Historic Market Size by Region (2017-2022)

2.2.3 Hepatitis C Virus (HCV) Forecasted Market Size by Region (2023-2028)

2.3 Hepatitis C Virus (HCV) Market Dynamics

2.3.1 Hepatitis C Virus (HCV) Industry Trends

2.3.2 Hepatitis C Virus (HCV) Market Drivers

2.3.3 Hepatitis C Virus (HCV) Market Challenges

2.3.4 Hepatitis C Virus (HCV) Market Restraints

3.1 Global Top Hepatitis C Virus (HCV) Players by Revenue

3.1.1 Global Top Hepatitis C Virus (HCV) Players by Revenue (2017-2022)

3.1.2 Global Hepatitis C Virus (HCV) Revenue Market Share by Players (2017-2022)

3.2 Global Hepatitis C Virus (HCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Revenue

3.4 Global Hepatitis C Virus (HCV) Market Concentration Ratio

3.4.1 Global Hepatitis C Virus (HCV) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Revenue in 2021

3.5 Hepatitis C Virus (HCV) Key Players Head office and Area Served

3.6 Key Players Hepatitis C Virus (HCV) Product Solution and Service

3.7 Date of Enter into Hepatitis C Virus (HCV) Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Hepatitis C Virus (HCV) Historic Market Size by Type (2017-2022)

4.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2023-2028)

5.1 Global Hepatitis C Virus (HCV) Historic Market Size by Application (2017-2022)

5.2 Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2023-2028)

6.1 North America Hepatitis C Virus (HCV) Market Size (2017-2028)

6.2 North America Hepatitis C Virus (HCV) Market Size by Type

6.2.1 North America Hepatitis C Virus (HCV) Market Size by Type (2017-2022)

6.2.2 North America Hepatitis C Virus (HCV) Market Size by Type (2023-2028)

6.2.3 North America Hepatitis C Virus (HCV) Market Share by Type (2017-2028)

6.3 North America Hepatitis C Virus (HCV) Market Size by Application

6.3.1 North America Hepatitis C Virus (HCV) Market Size by Application (2017-2022)

6.3.2 North America Hepatitis C Virus (HCV) Market Size by Application (2023-2028)

6.3.3 North America Hepatitis C Virus (HCV) Market Share by Application (2017-2028)

6.4 North America Hepatitis C Virus (HCV) Market Size by Country

6.4.1 North America Hepatitis C Virus (HCV) Market Size by Country (2017-2022)

6.4.2 North America Hepatitis C Virus (HCV) Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7.1 Europe Hepatitis C Virus (HCV) Market Size (2017-2028)

7.2 Europe Hepatitis C Virus (HCV) Market Size by Type

7.2.1 Europe Hepatitis C Virus (HCV) Market Size by Type (2017-2022)

7.2.2 Europe Hepatitis C Virus (HCV) Market Size by Type (2023-2028)

7.2.3 Europe Hepatitis C Virus (HCV) Market Share by Type (2017-2028)

7.3 Europe Hepatitis C Virus (HCV) Market Size by Application

7.3.1 Europe Hepatitis C Virus (HCV) Market Size by Application (2017-2022)

7.3.2 Europe Hepatitis C Virus (HCV) Market Size by Application (2023-2028)

7.3.3 Europe Hepatitis C Virus (HCV) Market Share by Application (2017-2028)

7.4 Europe Hepatitis C Virus (HCV) Market Size by Country

7.4.1 Europe Hepatitis C Virus (HCV) Market Size by Country (2017-2022)

7.4.2 Europe Hepatitis C Virus (HCV) Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size (2017-2028)

8.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type

8.2.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Hepatitis C Virus (HCV) Market Share by Type (2017-2028)

8.3 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application

8.3.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Hepatitis C Virus (HCV) Market Share by Application (2017-2028)

8.4 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region

8.4.1 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Hepatitis C Virus (HCV) Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Hepatitis C Virus (HCV) Market Size (2017-2028)

9.2 Latin America Hepatitis C Virus (HCV) Market Size by Type

9.2.1 Latin America Hepatitis C Virus (HCV) Market Size by Type (2017-2022)

9.2.2 Latin America Hepatitis C Virus (HCV) Market Size by Type (2023-2028)

9.2.3 Latin America Hepatitis C Virus (HCV) Market Share by Type (2017-2028)

9.3 Latin America Hepatitis C Virus (HCV) Market Size by Application

9.3.1 Latin America Hepatitis C Virus (HCV) Market Size by Application (2017-2022)

9.3.2 Latin America Hepatitis C Virus (HCV) Market Size by Application (2023-2028)

9.3.3 Latin America Hepatitis C Virus (HCV) Market Share by Application (2017-2028)

9.4 Latin America Hepatitis C Virus (HCV) Market Size by Country

9.4.1 Latin America Hepatitis C Virus (HCV) Market Size by Country (2017-2022)

9.4.2 Latin America Hepatitis C Virus (HCV) Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size (2017-2028)

10.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type

10.2.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Hepatitis C Virus (HCV) Market Share by Type (2017-2028)

10.3 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application

10.3.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Hepatitis C Virus (HCV) Market Share by Application (2017-2028)

10.4 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country

10.4.1 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Hepatitis C Virus (HCV) Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Gilead

11.1.1 Gilead Company Details

11.1.2 Gilead Business Overview

11.1.3 Gilead Hepatitis C Virus (HCV) Introduction

11.1.4 Gilead Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.1.5 Gilead Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Hepatitis C Virus (HCV) Introduction

11.2.4 Merck Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.2.5 Merck Recent Developments

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Hepatitis C Virus (HCV) Introduction

11.3.4 AbbVie Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.3.5 AbbVie Recent Developments

11.4 J&J

11.4.1 J&J Company Details

11.4.2 J&J Business Overview

11.4.3 J&J Hepatitis C Virus (HCV) Introduction

11.4.4 J&J Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.4.5 J&J Recent Developments

11.5 Bristol-Myers Squibb

11.5.1 Bristol-Myers Squibb Company Details

11.5.2 Bristol-Myers Squibb Business Overview

11.5.3 Bristol-Myers Squibb Hepatitis C Virus (HCV) Introduction

11.5.4 Bristol-Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.5.5 Bristol-Myers Squibb Recent Developments

11.6 Kawin

11.6.1 Kawin Company Details

11.6.2 Kawin Business Overview

11.6.3 Kawin Hepatitis C Virus (HCV) Introduction

11.6.4 Kawin Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.6.5 Kawin Recent Developments

11.7 Abbott

11.7.1 Abbott Company Details

11.7.2 Abbott Business Overview

11.7.3 Abbott Hepatitis C Virus (HCV) Introduction

11.7.4 Abbott Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.7.5 Abbott Recent Developments

11.8 Siemens Healthineers

11.8.1 Siemens Healthineers Company Details

11.8.2 Siemens Healthineers Business Overview

11.8.3 Siemens Healthineers Hepatitis C Virus (HCV) Introduction

11.8.4 Siemens Healthineers Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.8.5 Siemens Healthineers Recent Developments

11.9 Roche Diagnostics

11.9.1 Roche Diagnostics Company Details

11.9.2 Roche Diagnostics Business Overview

11.9.3 Roche Diagnostics Hepatitis C Virus (HCV) Introduction

11.9.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.9.5 Roche Diagnostics Recent Developments

11.10 altona Diagnostics

11.10.1 altona Diagnostics Company Details

11.10.2 altona Diagnostics Business Overview

11.10.3 altona Diagnostics Hepatitis C Virus (HCV) Introduction

11.10.4 altona Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.10.5 altona Diagnostics Recent Developments

11.11 GeneProof

11.11.1 GeneProof Company Details

11.11.2 GeneProof Business Overview

11.11.3 GeneProof Hepatitis C Virus (HCV) Introduction

11.11.4 GeneProof Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.11.5 GeneProof Recent Developments

11.12 Sansure Biotech

11.12.1 Sansure Biotech Company Details

11.12.2 Sansure Biotech Business Overview

11.12.3 Sansure Biotech Hepatitis C Virus (HCV) Introduction

11.12.4 Sansure Biotech Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.12.5 Sansure Biotech Recent Developments

11.13 Daan Gene

11.13.1 Daan Gene Company Details

11.13.2 Daan Gene Business Overview

11.13.3 Daan Gene Hepatitis C Virus (HCV) Introduction

11.13.4 Daan Gene Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.13.5 Daan Gene Recent Developments

11.14 BGI Group

11.14.1 BGI Group Company Details

11.14.2 BGI Group Business Overview

11.14.3 BGI Group Hepatitis C Virus (HCV) Introduction

11.14.4 BGI Group Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.14.5 BGI Group Recent Developments

11.15 Abiores

11.15.1 Abiores Company Details

11.15.2 Abiores Business Overview

11.15.3 Abiores Hepatitis C Virus (HCV) Introduction

11.15.4 Abiores Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.15.5 Abiores Recent Developments

11.16 ACON Biotech

11.16.1 ACON Biotech Company Details

11.16.2 ACON Biotech Business Overview

11.16.3 ACON Biotech Hepatitis C Virus (HCV) Introduction

11.16.4 ACON Biotech Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.16.5 ACON Biotech Recent Developments

11.17 Nectar Lifesciences

11.17.1 Nectar Lifesciences Company Details

11.17.2 Nectar Lifesciences Business Overview

11.17.3 Nectar Lifesciences Hepatitis C Virus (HCV) Introduction

11.17.4 Nectar Lifesciences Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.17.5 Nectar Lifesciences Recent Developments

11.18 Everlywell

11.18.1 Everlywell Company Details

11.18.2 Everlywell Business Overview

11.18.3 Everlywell Hepatitis C Virus (HCV) Introduction

11.18.4 Everlywell Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.18.5 Everlywell Recent Developments

11.19 bioLytical

11.19.1 bioLytical Company Details

11.19.2 bioLytical Business Overview

11.19.3 bioLytical Hepatitis C Virus (HCV) Introduction

11.19.4 bioLytical Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.19.5 bioLytical Recent Developments

11.20 Liferiver

11.20.1 Liferiver Company Details

11.20.2 Liferiver Business Overview

11.20.3 Liferiver Hepatitis C Virus (HCV) Introduction

11.20.4 Liferiver Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.20.5 Liferiver Recent Developments

11.21 3B BlackBio Biotech India Limited

11.21.1 3B BlackBio Biotech India Limited Company Details

11.21.2 3B BlackBio Biotech India Limited Business Overview

11.21.3 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Introduction

11.21.4 3B BlackBio Biotech India Limited Revenue in Hepatitis C Virus (HCV) Business (2017-2022)

11.21.5 3B BlackBio Biotech India Limited Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Global Hepatitis C Virus (HCV) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Hepatitis C Drugs

    Table 3. Key Players of Hepatitis C Test Kit

    Table 4. Global Hepatitis C Virus (HCV) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 5. Global Hepatitis C Virus (HCV) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 6. Global Hepatitis C Virus (HCV) Market Size by Region (2017-2022) & (US$ Million)

    Table 7. Global Hepatitis C Virus (HCV) Market Share by Region (2017-2022)

    Table 8. Global Hepatitis C Virus (HCV) Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 9. Global Hepatitis C Virus (HCV) Market Share by Region (2023-2028)

    Table 10. Hepatitis C Virus (HCV) Market Trends

    Table 11. Hepatitis C Virus (HCV) Market Drivers

    Table 12. Hepatitis C Virus (HCV) Market Challenges

    Table 13. Hepatitis C Virus (HCV) Market Restraints

    Table 14. Global Hepatitis C Virus (HCV) Revenue by Players (2017-2022) & (US$ Million)

    Table 15. Global Hepatitis C Virus (HCV) Revenue Share by Players (2017-2022)

    Table 16. Global Top Hepatitis C Virus (HCV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) as of 2021)

    Table 17. Ranking of Global Top Hepatitis C Virus (HCV) Companies by Revenue (US$ Million) in 2021

    Table 18. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Revenue (CR5 and HHI) & (2017-2022)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Hepatitis C Virus (HCV) Product Solution and Service

    Table 21. Date of Enter into Hepatitis C Virus (HCV) Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)

    Table 24. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2017-2022)

    Table 25. Global Hepatitis C Virus (HCV) Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 26. Global Hepatitis C Virus (HCV) Revenue Market Share by Type (2023-2028)

    Table 27. Global Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)

    Table 28. Global Hepatitis C Virus (HCV) Revenue Share by Application (2017-2022)

    Table 29. Global Hepatitis C Virus (HCV) Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 30. Global Hepatitis C Virus (HCV) Revenue Share by Application (2023-2028)

    Table 31. North America Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)

    Table 32. North America Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)

    Table 33. North America Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)

    Table 34. North America Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)

    Table 35. North America Hepatitis C Virus (HCV) Market Size by Country (2017-2022) & (US$ Million)

    Table 36. North America Hepatitis C Virus (HCV) Market Size by Country (2023-2028) & (US$ Million)

    Table 37. Europe Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)

    Table 38. Europe Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)

    Table 39. Europe Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)

    Table 40. Europe Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)

    Table 41. Europe Hepatitis C Virus (HCV) Market Size by Country (2017-2022) & (US$ Million)

    Table 42. Europe Hepatitis C Virus (HCV) Market Size by Country (2023-2028) & (US$ Million)

    Table 43. Asia Pacific Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)

    Table 44. Asia Pacific Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)

    Table 45. Asia Pacific Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)

    Table 46. Asia Pacific Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)

    Table 47. Asia Pacific Hepatitis C Virus (HCV) Market Size by Region (2017-2022) & (US$ Million)

    Table 48. Asia Pacific Hepatitis C Virus (HCV) Market Size by Region (2023-2028) & (US$ Million)

    Table 49. Latin America Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)

    Table 50. Latin America Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)

    Table 51. Latin America Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)

    Table 52. Latin America Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)

    Table 53. Latin America Hepatitis C Virus (HCV) Market Size by Country (2017-2022) & (US$ Million)

    Table 54. Latin America Hepatitis C Virus (HCV) Market Size by Country (2023-2028) & (US$ Million)

    Table 55. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Type (2017-2022) & (US$ Million)

    Table 56. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Type (2023-2028) & (US$ Million)

    Table 57. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Application (2017-2022) & (US$ Million)

    Table 58. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Application (2023-2028) & (US$ Million)

    Table 59. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Country (2017-2022) & (US$ Million)

    Table 60. Middle East and Africa Hepatitis C Virus (HCV) Market Size by Country (2023-2028) & (US$ Million)

    Table 61. Gilead Company Details

    Table 62. Gilead Business Overview

    Table 63. Gilead Hepatitis C Virus (HCV) Product

    Table 64. Gilead Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 65. Gilead Recent Developments

    Table 66. Merck Company Details

    Table 67. Merck Business Overview

    Table 68. Merck Hepatitis C Virus (HCV) Product

    Table 69. Merck Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 70. Merck Recent Developments

    Table 71. AbbVie Company Details

    Table 72. AbbVie Business Overview

    Table 73. AbbVie Hepatitis C Virus (HCV) Product

    Table 74. AbbVie Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 75. AbbVie Recent Developments

    Table 76. J&J Company Details

    Table 77. J&J Business Overview

    Table 78. J&J Hepatitis C Virus (HCV) Product

    Table 79. J&J Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 80. J&J Recent Developments

    Table 81. Bristol-Myers Squibb Company Details

    Table 82. Bristol-Myers Squibb Business Overview

    Table 83. Bristol-Myers Squibb Hepatitis C Virus (HCV) Product

    Table 84. Bristol-Myers Squibb Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 85. Bristol-Myers Squibb Recent Developments

    Table 86. Kawin Company Details

    Table 87. Kawin Business Overview

    Table 88. Kawin Hepatitis C Virus (HCV) Product

    Table 89. Kawin Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 90. Kawin Recent Developments

    Table 91. Abbott Company Details

    Table 92. Abbott Business Overview

    Table 93. Abbott Hepatitis C Virus (HCV) Product

    Table 94. Abbott Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 95. Abbott Recent Developments

    Table 96. Siemens Healthineers Company Details

    Table 97. Siemens Healthineers Business Overview

    Table 98. Siemens Healthineers Hepatitis C Virus (HCV) Product

    Table 99. Siemens Healthineers Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 100. Siemens Healthineers Recent Developments

    Table 101. Roche Diagnostics Company Details

    Table 102. Roche Diagnostics Business Overview

    Table 103. Roche Diagnostics Hepatitis C Virus (HCV) Product

    Table 104. Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 105. Roche Diagnostics Recent Developments

    Table 106. altona Diagnostics Company Details

    Table 107. altona Diagnostics Business Overview

    Table 108. altona Diagnostics Hepatitis C Virus (HCV) Product

    Table 109. altona Diagnostics Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 110. altona Diagnostics Recent Developments

    Table 111. GeneProof Company Details

    Table 112. GeneProof Business Overview

    Table 113. GeneProof Hepatitis C Virus (HCV) Product

    Table 114. GeneProof Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 115. GeneProof Recent Developments

    Table 116. Sansure Biotech Company Details

    Table 117. Sansure Biotech Business Overview

    Table 118. Sansure Biotech Hepatitis C Virus (HCV) Product

    Table 119. Sansure Biotech Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 120. Sansure Biotech Recent Developments

    Table 121. Daan Gene Company Details

    Table 122. Daan Gene Business Overview

    Table 123. Daan Gene Hepatitis C Virus (HCV) Product

    Table 124. Daan Gene Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 125. Daan Gene Recent Developments

    Table 126. BGI Group Company Details

    Table 127. BGI Group Business Overview

    Table 128. BGI Group Hepatitis C Virus (HCV) Product

    Table 129. BGI Group Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 130. BGI Group Recent Developments

    Table 131. Abiores Company Details

    Table 132. Abiores Business Overview

    Table 133. Abiores Hepatitis C Virus (HCV) Product

    Table 134. Abiores Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 135. Abiores Recent Developments

    Table 136. ACON Biotech Company Details

    Table 137. ACON Biotech Business Overview

    Table 138. ACON Biotech Hepatitis C Virus (HCV) Product

    Table 139. ACON Biotech Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 140. ACON Biotech Recent Developments

    Table 141. Nectar Lifesciences Company Details

    Table 142. Nectar Lifesciences Business Overview

    Table 143. Nectar Lifesciences Hepatitis C Virus (HCV) Product

    Table 144. Nectar Lifesciences Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 145. Nectar Lifesciences Recent Developments

    Table 146. Everlywell Company Details

    Table 147. Everlywell Business Overview

    Table 148. Everlywell Hepatitis C Virus (HCV) Product

    Table 149. Everlywell Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 150. Everlywell Recent Developments

    Table 151. bioLytical Company Details

    Table 152. bioLytical Business Overview

    Table 153. bioLytical Hepatitis C Virus (HCV) Product

    Table 154. bioLytical Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 155. bioLytical Recent Developments

    Table 156. Liferiver Company Details

    Table 157. Liferiver Business Overview

    Table 158. Liferiver Hepatitis C Virus (HCV) Product

    Table 159. Liferiver Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 160. Liferiver Recent Developments

    Table 161. 3B BlackBio Biotech India Limited Company Details

    Table 162. 3B BlackBio Biotech India Limited Business Overview

    Table 163. 3B BlackBio Biotech India Limited Hepatitis C Virus (HCV) Product

    Table 164. 3B BlackBio Biotech India Limited Revenue in Hepatitis C Virus (HCV) Business (2017-2022) & (US$ Million)

    Table 165. 3B BlackBio Biotech India Limited Recent Developments

    Table 166. Research Programs/Design for This Report

    Table 167. Key Data Information from Secondary Sources

    Table 168. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Hepatitis C Virus (HCV) Market Share by Type: 2021 VS 2028

    Figure 2. Hepatitis C Drugs Features

    Figure 3. Hepatitis C Test Kit Features

    Figure 4. Global Hepatitis C Virus (HCV) Market Share by Application: 2021 VS 2028

    Figure 5. Hospitals Case Studies

    Figure 6. Ambulatory Surgical Centers Case Studies

    Figure 7. Diagnostic Centers Case Studies

    Figure 8. Hepatitis C Virus (HCV) Report Years Considered

    Figure 9. Global Hepatitis C Virus (HCV) Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 10. Global Hepatitis C Virus (HCV) Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global Hepatitis C Virus (HCV) Market Share by Region: 2021 VS 2028

    Figure 12. Global Hepatitis C Virus (HCV) Market Share by Players in 2021

    Figure 13. Global Top Hepatitis C Virus (HCV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis C Virus (HCV) as of 2021)

    Figure 14. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Revenue in 2021

    Figure 15. North America Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)

    Figure 16. North America Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)

    Figure 17. North America Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)

    Figure 18. North America Hepatitis C Virus (HCV) Market Size Share by Country (2017-2028)

    Figure 19. United States Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Canada Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Europe Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)

    Figure 22. Europe Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)

    Figure 23. Europe Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)

    Figure 24. Europe Hepatitis C Virus (HCV) Market Size Share by Country (2017-2028)

    Figure 25. Germany Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. France Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. U.K. Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Italy Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Russia Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Nordic Countries Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Asia-Pacific Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)

    Figure 32. Asia Pacific Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)

    Figure 33. Asia Pacific Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)

    Figure 34. Asia Pacific Hepatitis C Virus (HCV) Market Size Share by Region (2017-2028)

    Figure 35. China Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Japan Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. South Korea Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. Southeast Asia Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. India Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Australia Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Latin America Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)

    Figure 42. Latin America Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)

    Figure 43. Latin America Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)

    Figure 44. Latin America Hepatitis C Virus (HCV) Market Size Share by Country (2017-2028)

    Figure 45. Mexico Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 46. Brazil Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 47. Middle East & Africa Hepatitis C Virus (HCV) Market Size YoY (2017-2028) & (US$ Million)

    Figure 48. Middle East and Africa Hepatitis C Virus (HCV) Market Size Market Share by Type (2017-2028)

    Figure 49. Middle East and Africa Hepatitis C Virus (HCV) Market Size Market Share by Application (2017-2028)

    Figure 50. Middle East and Africa Hepatitis C Virus (HCV) Market Size Share by Country (2017-2028)

    Figure 51. Turkey Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 52. Saudi Arabia Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 53. UAE Hepatitis C Virus (HCV) Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 54. Gilead Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 55. Merck Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 56. AbbVie Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 57. J&J Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 59. Kawin Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 60. Abbott Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 61. Siemens Healthineers Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 62. Roche Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 63. altona Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 64. GeneProof Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 65. Sansure Biotech Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 66. Daan Gene Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 67. BGI Group Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 68. Abiores Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 69. ACON Biotech Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 70. Nectar Lifesciences Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 71. Everlywell Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 72. bioLytical Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 73. Liferiver Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 74. 3B BlackBio Biotech India Limited Revenue Growth Rate in Hepatitis C Virus (HCV) Business (2017-2022)

    Figure 75. Bottom-up and Top-down Approaches for This Report

    Figure 76. Data Triangulation

    Figure 77. Key Executives Interviewed